Female fertility following dose-adjusted EPOCH-R chemotherapy in primary mediastinal B-cell lymphomas.

about

Female fertility following dose-adjusted EPOCH-R chemotherapy in primary mediastinal B-cell lymphomas.

Item

http://www.wikidata.org/entity/Q39763050

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Female fertility following dos ...... mediastinal B-cell lymphomas.

@en

Female fertility following dos ...... mediastinal B-cell lymphomas.

@nl

type

Item

label

Female fertility following dos ...... mediastinal B-cell lymphomas.

@en

Female fertility following dos ...... mediastinal B-cell lymphomas.

@nl

prefLabel

Female fertility following dos ...... mediastinal B-cell lymphomas.

@en

Female fertility following dos ...... mediastinal B-cell lymphomas.

@nl

P1476

Female fertility following dos ...... mediastinal B-cell lymphomas.

@en

P2093

Catherine Lai

http://www.w3.org/2001/XMLSchema#string

Cliona Grant

http://www.w3.org/2001/XMLSchema#string

Helen Gharwan

http://www.w3.org/2001/XMLSchema#string

Kieron Dunleavy

http://www.w3.org/2001/XMLSchema#string

Margaret Shovlin

http://www.w3.org/2001/XMLSchema#string

Seth M Steinberg

http://www.w3.org/2001/XMLSchema#string

Tito Fojo

http://www.w3.org/2001/XMLSchema#string

Wyndham H Wilson

http://www.w3.org/2001/XMLSchema#string

P2860

Human ovarian reserve from conception to the menopause

Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers

How do chemotherapeutic agents damage the ovary?

Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women.

Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update.

Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise.

A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.

Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.

Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients.

Anti-Müllerian hormone and ovarian dysfunction.

P304

1616-1624

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2015.1118476

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27183887

http://www.w3.org/2001/XMLSchema#string